CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-06 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −25,157 | 0 | ||
| 2020-11-05 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −8,809 | 0 | ||
| 2020-11-05 | Hippel James Chief Financial Officer | Option exercise | +8,809 | $108.49 | $956K | 17,946 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −398 | $280.28 | $112K | 17,548 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −203 | $281.27 | $57K | 17,345 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −1,674 | $282.52 | $473K | 15,671 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −325 | $283.64 | $92K | 15,346 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −1,630 | $285.12 | $465K | 13,716 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −121 | $287.15 | $35K | 13,595 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −3,249 | $287.98 | $936K | 10,346 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −359 | $289.39 | $104K | 9,987 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −750 | $291.06 | $218K | 9,237 |
| 2020-11-05 | Hippel James Chief Financial Officer | Sale | −100 | $293.66 | $29K | 9,137 |
| 2020-11-04 | Hippel James Chief Financial Officer | Option exercise | +7,100 | $108.49 | $770K | 16,237 |
| 2020-11-04 | Hippel James Chief Financial Officer | Sale | −1,555 | $272.71 | $424K | 14,682 |
| 2020-11-04 | Hippel James Chief Financial Officer | Sale | −2,745 | $273.65 | $751K | 11,937 |
| 2020-11-04 | Hippel James Chief Financial Officer | Sale | −1,600 | $274.53 | $439K | 10,337 |
| 2020-11-04 | Hippel James Chief Financial Officer | Sale | −1,200 | $275.79 | $331K | 9,137 |
| 2020-11-04 | Hippel James Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −7,100 | 7,100 | ||
| 2020-10-29 | BAUMGARTNER ROBERT V Director | Grant or award | +391 | 9,612 |
Page 39 of 53 · 1,043 trades